See also this year's filing and all EDGAR filings for this company.
PDF Report 0001069308_2023_Acer_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001069308, Acer Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,516,698 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,647,267 |
| 2 | PropertyPlantAndEquipmentNet | 214,578 |
| 3 | remainder_Assets | 245,683 |
| 4 | LiabilitiesCurrent | 18,951,700 |
| 5 | LiabilitiesNoncurrent | 145,665 |
| 6 | remainder_Liabilities | 9,288,133 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,246,916 |
| 9 | ResearchAndDevelopmentExpense | 11,003,370 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,236,590 |
| 12 | remainder_NetIncome | -1,557,942 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,624,226 |
| 1 | Liabilities | 28,385,498 |
| 2 | Expenses | 23,250,286 |
| 3 | Revenues | 1,236,590 |
| 4 | StockholdersEquity | -16,761,272 |
| 5 | NetIncome | -23,571,638 |
| 6 | ComprehensiveNetIncome | -23,571,638 |
| 7 | BaseVar | 33,027,271 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.00 |
| 9 | EconomicCapitalRatio | 0.685 |
Edgar->Model Mapping
Feature Distribution
Change over Time
